Efficacy of bipolar transurethral resection of the prostate using TURIS: our short term experience
DOI:
https://doi.org/10.18203/2349-2902.isj20191869Keywords:
Bipolar transurethral resection of prostate, Benign prostatic hyperplasia, Urethral strictureAbstract
Background: Objective of the study was to report our short term experience regarding efficacy of bipolar transurethral resection of prostate using TURIS (transurethral resection in saline) system.
Methods: Between May 2016 to April 2017 49 consecutive patients underwent bipolar transurethral resection of prostate (B-TURP) at our institute. All patients were evaluated preoperatively by physical examination, ultrasonography and laboratory studies, including measurement of hemoglobin, serum sodium, and prostate specific antigen levels. Patients were assessed postoperatively at three, six and 18 months.
Results: The mean age of the patients was 64.83±7.47 years and mean preoperative prostate volume was 64.73±13.59 ml. The mean preoperative hemoglobin was 13.32±0.9 g/l and mean postoperative hemoglobin was 12.09±1.11 g/l. The mean resection time was 57.02±14.37 minutes and mean resected specimen weight was 41.69±12.15 gm. The mean preoperative maximum urinary flow rate (Qmax) was 8.6±1.17 ml/s and mean Qmax at three, six and 18 months follow up was 18.85±2.15, 19.43±1.49 and 18.98±1.6 ml/s respectively. The mean preoperative international prostate symptom score (IPSS) was 26.32±2.69 and mean IPSS at three, six and 18 months follow up was 6.68±1.36, 6.47±0.79 and 6.30±0.9 respectively. Only one patient developed urethral stricture during follow up.
Conclusions: The B-TURP is efficacious and results in significant improvement in IPSS and Qmax. The urethral stricture rate after B-TURP is not different from monopolar TURP.
References
AUA Practice Guidelines Committee. AUA guidelines on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003;170:530-47.
Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173:1256-61.
Thiruchelvam N. Surgical therapy of benign prostatic hypertrophy/bladder outflow obstruction. Indian J Urol. 2014;30(2):202-7.
Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180:246-9.
Finley DS, Beck S, Szabo RJ. Bipolar saline TURP for large prostate glands. Scientific World Journal 2007;7:1558-62.
Tefekli A, Muslumanoghu AY, Baykal M, Binbay M, Tas A, Altunrende F, et al. A hybrid technique using bipolar energy in transurethral prostate surgery: A prospective, randomized comparison. J Urol. 2005;174:1339-43.
Komura K, Inamoto T, Takai T, Uchmoto T, Saito K, Tanda N, et al. Incidence of urethral stricture after bipolar transurethral resection of the prostate using TURis: Results from a randomized trial. BJU Int. 2015;115:644-52.
Tan GH, Shah SA, Ali NM, Goh EH, Singam P, Ho CCK, et al. Urethral strictures after bipolar transurethral resection of prostate may be linked to slow resection rate. Investig Clin Urol. 2017;58:186-91.
Wendt-Nordahl G, Hacker A, Reoch O, Djavan B, Alken P, Michel MS, et al. The Vista system: a new bipolar resection device for endourological procedures: Comparison with conventional resectoscope. Eur Urol. 2004;46:586-90.
Singh H, Desai MR, Shrivastava P, Vani K. Bipolar versus monopolar transurethral resection of prostate: Randomised controlled study. J Endourol. 2005;19:333-8.
Hon NH, Brathwaite D, Hussain Z, Ghiblawi S, Brace H, Hayne D, et al. A prospective randomized trial comparing conventional transurethral prostate resection with plasmakinetic vaporization of the prostate: Physiological changes, early complications and long term follow up. J Urol. 2006;176:205-9.
Tang Y, Li J, Pu C, Bai Y, Yuan H, Wei Q, et al. Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: A systematic review and meta-analysis. J Endourol. 2014;28:1107-14.
Zamel AA, Kassem AI, Orban TZ, Saad IR, Bedair AS. Urethral stricture disease after bipolar prostatectomy: Is it a concern? Afr J Urol. 2018;24:24-7.
Chen Q, Zhang L, Fan QL, Zhou J, Peng YB, Wang Z. Bipolar transurethral resection in saline vs. traditional monopolar resection of the prostate: Results of a randomised trial with a 2-year follow-up. BJU Int. 2010;106:1339-43.
Fagerstrom T, Nyman CR, Hahn RG. Bipolar transurethral resection of the prostate cause less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients. BJU Int. 2010;105:1560-4.
Michielsen DP, Debacker T, De Boe V, Van Lersberghe C, Kaufman L, Braeckmann JG, et al. Bipolar transurethral resection in saline – An alternative surgical treatment for bladder outlet obstruction? J Urol. 2007;178:2035-9.
Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW, et al. A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol. 2007;52:517-22.
Michielsen DP, Coomans D. Urethral strictures and bipolar transurethral resection in saline of the prostate: fact or fiction? J Endourol. 2010;24:1333-7.
Sciarra A, Salciccia S, Albanesi L, Cardi A, D’Eramo G, Di Silverio F. Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate. Urology. 2005;66:1218-22.
